Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Işıl Var

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|October 10, 2019
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB IsolatesManaf AlMatar, Işıl Var, Begüm Kayar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2017
New drugs for the treatment of Mycobacterium tuberculosis infectionManaf AlMatar, Husam AlMandeal, Işıl Var, et al.
Current Molecular Pharmacology|September 25, 2024
Mutations in Rv0678, Rv2535c, and Rv1979c Confer Resistance to Bedaquiline in Clinical Isolates of Mycobacterium TuberculosisKhaoula Balgouthi, Manaf AlMatar, Hamza Saghrouchni, et al.
Current Drug Targets|June 23, 2020
A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological ApproachesManaf AlMatar, Osman Albarri, Essam A Makky, et al.
Pharmacological Reports : PR|February 24, 2018
Novel compounds targeting InhA for TB therapyManaf AlMatar, Essam A Makky, Işıl Var, et al.
Mini Reviews in Medicinal Chemistry|August 20, 2020
An Overview of the Activities of Cefiderocol Against Sensitive and Multidrug- Resistant (MDR) BacteriaManaf AlMatar, Osman Albarri, Essam A Makky, et al.
Current Protein & Peptide Science|July 27, 2023
Bacterial Pathogens: Potential Source For Antimicrobial PeptidesManaf AlMatar, Osman Albarri, Raja Lakhal, et al.
Current Microbiology|October 28, 2016
Are There Any Other Compounds Isolated From Dermacoccus spp at All?Manaf AlMatar, Mohamed Eldeeb, Essam A Makky, et al.
Pharmacological Research|October 29, 2017
Antimicrobial peptides as an alternative to anti-tuberculosis drugsManaf AlMatar, Essam A Makky, Gülfer Yakıcı, et al.
Current Pharmaceutical Biotechnology|March 12, 2019
Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical IsolatesManaf AlMatar, Işıl Var, Begüm Kayar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine, Metabolic & Immune Disorders Drug Targets|October 10, 2019
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB IsolatesManaf AlMatar, Işıl Var, Begüm Kayar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2017
New drugs for the treatment of Mycobacterium tuberculosis infectionManaf AlMatar, Husam AlMandeal, Işıl Var, et al.
Current Molecular Pharmacology|September 25, 2024
Mutations in Rv0678, Rv2535c, and Rv1979c Confer Resistance to Bedaquiline in Clinical Isolates of Mycobacterium TuberculosisKhaoula Balgouthi, Manaf AlMatar, Hamza Saghrouchni, et al.
Current Drug Targets|June 23, 2020
A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological ApproachesManaf AlMatar, Osman Albarri, Essam A Makky, et al.
Pharmacological Reports : PR|February 24, 2018
Novel compounds targeting InhA for TB therapyManaf AlMatar, Essam A Makky, Işıl Var, et al.
Mini Reviews in Medicinal Chemistry|August 20, 2020
An Overview of the Activities of Cefiderocol Against Sensitive and Multidrug- Resistant (MDR) BacteriaManaf AlMatar, Osman Albarri, Essam A Makky, et al.
Current Protein & Peptide Science|July 27, 2023
Bacterial Pathogens: Potential Source For Antimicrobial PeptidesManaf AlMatar, Osman Albarri, Raja Lakhal, et al.
Current Microbiology|October 28, 2016
Are There Any Other Compounds Isolated From Dermacoccus spp at All?Manaf AlMatar, Mohamed Eldeeb, Essam A Makky, et al.
Pharmacological Research|October 29, 2017
Antimicrobial peptides as an alternative to anti-tuberculosis drugsManaf AlMatar, Essam A Makky, Gülfer Yakıcı, et al.
Current Pharmaceutical Biotechnology|March 12, 2019
Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical IsolatesManaf AlMatar, Işıl Var, Begüm Kayar, et al.
Pageof 2